Golimumab: A human anti-TNF-alpha monoclonal antibody for the treatment of autoimmune joint diseases
September 1st 2009Golimumab is a human anti-tumor necrosis factor (TNF)-alpha monoclonal antibody that was recently approved for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.